scispace - formally typeset
P

Peter M.A. Calverley

Researcher at University of Liverpool

Publications -  374
Citations -  42164

Peter M.A. Calverley is an academic researcher from University of Liverpool. The author has contributed to research in topics: COPD & Exacerbation. The author has an hindex of 80, co-authored 363 publications receiving 38558 citations. Previous affiliations of Peter M.A. Calverley include Aintree University Hospitals NHS Foundation Trust & Ghent University.

Papers
More filters
Journal ArticleDOI

Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial

TL;DR: In patients with persistent symptoms and/or raised CRP 14 days following a COPD exacerbation, an additional course of ciprofloxacin resulted in no additional benefit compared to placebo, which suggests that non-recovered exacerbations are not driven by ongoing bacterial infection and may potentially be targeted with anti-inflammatory therapy.
Journal ArticleDOI

International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials

TL;DR: Country contributing to chronic obstructive pulmonary disease trials differ consistently in their reporting of health care-defined exacerbations, which helps explain why large studies have been needed to show differences between treatments that decrease exacerbation risk.
Journal ArticleDOI

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)

Jean Bousquet, +344 more
TL;DR: This research presents a novel probabilistic procedure that allows for direct measurement of the response of the immune system to earthquake-triggered landsliding.
Journal ArticleDOI

New Pharmacotherapeutic Approaches for Chronic Obstructive Pulmonary Disease.

TL;DR: An overview of the latest data about the best way to treat chronic obstructive pulmonary disease is provided and some direction as to how these findings can be applied in practice is provided.